INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.70B / 21S · 11 late91 trades$26.34M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 33S33 trades$5.33M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

68,704 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
EC
Ellwanger Russell CraigChief Executive Officer
TSEMTOWER SEMICONDUCTOR LTD
Grant or award
A—
22.9K sh
Jul 2, 2026Jul 6, 2026
Page 583 of 1718
← PrevNext →
traded Jul 2, 2026
+4d
SEC Form 4

Evidence

9
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
80.9K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

9
PR
Powell RikkiChief Financial Officer
SSTKShutterstock, Inc.
Tax withholding
F$12K
1,233 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

9
RH
Robinson Mark HaymondGeneral Counsel and Secretary
GMEGameStop Corp.
Open-market sale · 10b5-1 plan
SELL$90K
3,957 sh
Jul 6, 2026Jul 6, 2026
traded Jul 6, 2026
+0dSEC Form 4

Evidence

9
NB
Nelson Kenza BemisSVP, General Counsel
HBIA.PKHILLS BANCORPORATION
Grant or award
A$1,984
50 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

9
HM
Hancock MarkDirector, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$577K
12.8K sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

9
MR
Marion Josh R.SVP and General Counsel
KOSKosmos Energy Ltd.
Grant or award · 10b5-1 plan
A—
64.2K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

9
HA
Hasson AviDirector
TSEMTOWER SEMICONDUCTOR LTD
Grant or award
A—
814 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

9
VM
Vakrat Wolkin MichalDirector
TSEMTOWER SEMICONDUCTOR LTD
Grant or award
A—
814 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

9
PT
Prengel Eric TheodoreChief Financial Officer
PDPagerDuty, Inc.
Grant or award
A—
600.0K sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

9
EA
Elstein AmirDirector
TSEMTOWER SEMICONDUCTOR LTD
Grant or award
A—
1,222 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

8
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M$261K
5,000 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

8
WM
Wittmann MichaelChief Operating Officer
INDIindie Semiconductor, Inc.
Option exercise
M—
12.5K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

8
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Tax withholding
F$33K
1,838 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

8
BS
Beatty Jonathan SMD, Head of Advisor Services
SCHWSCHWAB CHARLES CORP
Open-market sale · 10b5-1 plan
SELL$194K
2,000 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

8
WM
Wittmann MichaelChief Operating Officer
INDIindie Semiconductor, Inc.
Option exercise
M—
65.0K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

8
JD
Johnston James DavidExecutive VP, GC, CCO and Secy
SMCSummit Midstream Corp
Open-market sale · 10b5-1 plan
SELL$77K
2,600 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

8
MR
Marion Josh R.SVP and General Counsel
KOSKosmos Energy Ltd.
Open-market sale · 10b5-1 plan
SELL$51K
25.0K sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

8
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Open-market sale · 10b5-1 plan
SELL$5,455
137 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

8
BS
Beatty Jonathan SMD, Head of Advisor Services
SCHWSCHWAB CHARLES CORP
Open-market sale · 10b5-1 plan
SELL$200K
2,000 sh
Jul 6, 2026Jul 6, 2026
traded Jul 6, 2026
+0dSEC Form 4

Evidence

7
LD
Lentz DanielCFO & COO
CMRCCommerce.com, Inc.
Open-market sale · 10b5-1 plan
SELL$4,570
1,544 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

7
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$190K
600 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

7
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$219K
700 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

7
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$122K
396 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

6
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Option exercise · 10b5-1 plan
M—
207 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

6
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
612 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

6
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
781 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

6
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Option exercise · 10b5-1 plan
M—
207 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

5
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
18.5K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

5
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
80.9K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

5
HK
Hogan Catherine KiernanChief Operating Officer
ACNAccenture plc
Grant or award
A$21K
157 sh
Jul 5, 2026Jul 6, 2026
traded Jul 5, 2026
+1dSEC Form 4

Evidence

5
TK
Truong KristinaChief Accounting Officer
ENVXEnovix Corp
Tax withholding
F$3,420
638 sh
Jul 5, 2026Jul 6, 2026
traded Jul 5, 2026
+1dSEC Form 4

Evidence

5
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
22.1K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

5
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
18.5K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

5
CJ
Carroll Hugh JDirector
TXRHTexas Roadhouse, Inc.
Option exercise
M—
2,667 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

4
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$31K
100 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

4
BS
Beatty Jonathan SMD, Head of Advisor Services
SCHWSCHWAB CHARLES CORP
Tax withholding · 10b5-1 plan
F$96K
1,036 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

4
CK
Clark KyleDirector, SEE REMARKS
BETABETA Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$269K
15.0K sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

4
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$32K
104 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

4
LM
Lin MarkEVP and CFO
SMTCSEMTECH CORP
Tax withholding · 10b5-1 plan
F$253K
1,561 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence